Grown Rogue International (GRUSF) EBITDA Margin Growth (1y) (2010 - 2026)
Grown Rogue International (GRUSF) EBITDA Margin Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | -1,647.00 |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | -368.00 |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -17.00 |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | -341.00 |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -634.00 |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | -538.00 |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 40.00 |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Grown Rogue International | 110.47 Mn | 98.93 Mn | 5.37 Mn | 127.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 204.00 |
| Mar 31, 2026 | 1,101.00 |
| Dec 31, 2025 | -892.00 |
| Sep 30, 2025 | -714.00 |
| Jun 30, 2025 | -1,735.00 |
| Mar 31, 2025 | -2,385.00 |
| Dec 31, 2024 | -1,149.00 |
| Jan 31, 2023 | 124.00 |
| Jan 31, 2022 | -8,086.00 |
| Oct 31, 2021 | 5,001.00 |
| Jul 31, 2021 | 10,061.00 |
| Apr 30, 2021 | 6,023.00 |
| Jan 31, 2021 | 11,004.00 |
| Oct 31, 2020 | 9,080.00 |
| Jul 31, 2020 | 3,558.00 |
| Apr 30, 2020 | 3,706.00 |
| Jan 31, 2020 | 54,225.00 |
| Oct 31, 2019 | 10,460.00 |
| Jul 31, 2019 | -5,381.00 |
| Apr 30, 2019 | 20,136.00 |